These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8913401)

  • 1. Effects of serotonin reuptake inhibitors on hemostasis.
    Alderman CP; Seshadri P; Ben-Tovim DI
    Ann Pharmacother; 1996 Nov; 30(11):1232-4. PubMed ID: 8913401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of antidepressants on hemostasis.
    Halperin D; Reber G
    Dialogues Clin Neurosci; 2007; 9(1):47-59. PubMed ID: 17506225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SSRI-induced bleeding: two case reports.
    Vandel P; Vandel S; Kantelip JP
    Therapie; 2001; 56(4):445-7. PubMed ID: 11677872
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluoxetine inhibition of 5-HT-potentiated platelet aggregation in whole blood.
    Bampalis VG; Khandoga AL; Siess W
    Thromb Haemost; 2010 Dec; 104(6):1272-4. PubMed ID: 20806122
    [No Abstract]   [Full Text] [Related]  

  • 5. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms.
    Andrade C; Sandarsh S; Chethan KB; Nagesh KS
    J Clin Psychiatry; 2010 Dec; 71(12):1565-75. PubMed ID: 21190637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs.
    Epperson CN; Jatlow PI; Czarkowski K; Anderson GM
    Pediatrics; 2003 Nov; 112(5):e425. PubMed ID: 14595087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of fluoxetine treatment on carbohydrate metabolism in human blood platelets: a 1H-NMR study.
    Tassini M; Vivi A; Gaggelli E; Valensin G; Laghi Pasini F; Puccetti L; Di Perri T
    Arch Biochem Biophys; 2002 Aug; 404(1):163-5. PubMed ID: 12127081
    [No Abstract]   [Full Text] [Related]  

  • 8. Selective serotonin reuptake inhibitors facilitate ANO6 (TMEM16F) current activation and phosphatidylserine exposure.
    Kim HJ; Jun I; Yoon JS; Jung J; Kim YK; Kim WK; Kim BJ; Song J; Kim SJ; Nam JH; Lee MG
    Pflugers Arch; 2015 Nov; 467(11):2243-56. PubMed ID: 25630304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BiteStrip analysis of the effect of fluoxetine and paroxetine on sleep bruxism.
    Isa Kara M; Ertaş ET; Ozen E; Atıcı M; Aksoy S; Erdogan MS; Kelebek S
    Arch Oral Biol; 2017 Aug; 80():69-74. PubMed ID: 28391088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bruising associated with the use of fluoxetine.
    Pai VB; Kelly MW
    Ann Pharmacother; 1996; 30(7-8):786-8. PubMed ID: 8826562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors.
    Skop BP; Brown TM
    Psychosomatics; 1996; 37(1):12-6. PubMed ID: 8600488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.
    Baumann P
    Clin Pharmacokinet; 1996 Dec; 31(6):444-69. PubMed ID: 8968657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy.
    Strawn JR; Mills JA; Croarkin PE
    J Child Adolesc Psychopharmacol; 2019 May; 29(4):250-255. PubMed ID: 30810350
    [No Abstract]   [Full Text] [Related]  

  • 14. Decreased serotonin content and reduced agonist-induced aggregation in platelets of patients chronically medicated with SSRI drugs.
    Bismuth-Evenzal Y; Gonopolsky Y; Gurwitz D; Iancu I; Weizman A; Rehavi M
    J Affect Disord; 2012 Jan; 136(1-2):99-103. PubMed ID: 21893349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal platelet aggregation associated with fluoxetine therapy.
    Alderman CP; Moritz CK; Ben-Tovim DI
    Ann Pharmacother; 1992 Dec; 26(12):1517-9. PubMed ID: 1482806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo identification and characterization of binding sites for selective serotonin reuptake inhibitors in mouse brain.
    Hirano K; Maruyama S; Kimura R; Kagawa Y; Yamada S
    Life Sci; 2004 Oct; 75(24):2933-45. PubMed ID: 15454344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Differential features of SSRIs].
    Cervera S
    Rev Med Univ Navarra; 1997; 41(4):245-57. PubMed ID: 10420965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of pre-operative platelet functions by thromboelastogram in patients selective serotonin reuptake inhibitors user and non-user.
    Yılmaz R; Yusifov M; Hacıbeyoğlu G; Arıcan Ş; Topal A
    Ulus Travma Acil Cerrahi Derg; 2022 Mar; 28(3):276-280. PubMed ID: 35485575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors.
    Centorrino F; Baldessarini RJ; Frankenburg FR; Kando J; Volpicelli SA; Flood JG
    Am J Psychiatry; 1996 Jun; 153(6):820-2. PubMed ID: 8633698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacogenetics of the selective serotonin reuptake inhibitors.
    Brøsen K
    Clin Investig; 1993 Dec; 71(12):1002-9. PubMed ID: 8124052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.